ACHE and early-onset autosomal dominant Alzheimer disease: Solanocapsine, a steroidal alkaloid, has shown potential therapeutic value as an inhibitor of acetylcholinesterase in patients with Alzheimer’s disease [51]; however, its anti-cancer pharmacological effects are yet to be studied.